HSBC Holdings
SGYP

HSBC Holdings’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

HSBC Holdings’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-9,500
Closed -$21K – 2636
2017
Q4 		$21K Hold
9,500
– – ﹤0.01% 2009
2017
Q3 		$28K Hold
9,500
– – ﹤0.01% 2268
2017
Q2 		$42K Buy
9,500
+3,000
+46% +$12.4K ﹤0.01% 2154
2017
Q1 		$30K Buy
+6,500
New +$37.7K ﹤0.01% 2092

Other funds holding SGYP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

HSBC Holdings's SGYP Position: Q2 2018 in Review

HSBC Holdings sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2018, closing a stake of 33,150 shares — an estimated $60K sold.

HSBC Holdings first reported a position in SGYP in Q4 2016 and held it in 6 quarters. The position peaked at $237K in Q4 2016. 137 funds tracked by Wall St. Rank hold SGYP as of Q2 2018.

  • HSBC Holdings reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2018 after selling out during the quarter.
  • HSBC Holdings sold 33,150 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2018, an estimated $60K.
  • HSBC Holdings first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2016 and held it in 6 quarters.
  • HSBC Holdings's Synergy Pharmaceuticals, Inc Common Stock position peaked at $237K in Q4 2016.
  • 137 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2018.

Based on HSBC Holdings's 13F filing for Q2 2018, filed 10 Aug 2018.